🇺🇸 Fentanyl- midazolam in United States

7 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cardio-Respiratory Arrest — 1 report (14.29%)
  2. Documented Hypersensitivity To Administered Drug — 1 report (14.29%)
  3. Electromechanical Dissociation — 1 report (14.29%)
  4. Hypotension — 1 report (14.29%)
  5. Pulmonary Oedema — 1 report (14.29%)
  6. Pulmonary Toxicity — 1 report (14.29%)
  7. Ventricular Fibrillation — 1 report (14.29%)

Source database →

Fentanyl- midazolam in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fentanyl- midazolam approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fentanyl- midazolam in United States?

Cairo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.